Modabpil, Ryan A.
HRN: 22-05-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/25/2023
04/01/2023
IV
4.5gms
Q12
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes